NCT01245764 2018-11-14GARDASILâ„¢ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)Merck Sharp & Dohme LLCPhase 3 Completed250 enrolled 20 charts
NCT00411749 2017-04-21V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)Merck Sharp & Dohme LLCPhase 2 Completed107 enrolled 12 charts
NCT00496626 2017-04-17An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED)Merck Sharp & Dohme LLCPhase 3 Completed600 enrolled 12 charts